12399456https://www.upal.com.my/zh/feeds/jobFeedKwongwahArray ( [0] => HTTP/1.1 200 OK [1] => Date: Fri, 10 Oct 2025 11:06:46 GMT [2] => Content-Type: text/xml; charset=utf-8 [3] => Connection: close [4] => Cache-Control: no-cache, private [5] => Cache-Control: no-cache, no-store, must-revalidate [6] => Nel: {"report_to":"cf-nel","success_fraction":0.0,"max_age":604800} [7] => x-frame-options: SAMEORIGIN [8] => x-content-type-options: nosniff [9] => x-xss-protection: 1; mode=block [10] => referrer-policy: strict-origin-when-cross-origin [11] => permissions-policy: geolocation=(), microphone=(), camera=() [12] => content-security-policy: default-src * 'unsafe-inline' 'unsafe-eval' data: blob:; script-src * 'unsafe-inline' 'unsafe-eval' data: blob:; style-src * 'unsafe-inline' data:; img-src * data: blob:; font-src * data:; connect-src *; frame-src *; object-src *; media-src *; child-src *; [13] => Server: cloudflare [14] => x-robots-tag: noindex, nofollow, nosnippet, noarchive [15] => strict-transport-security: max-age=31536000; includeSubDomains; preload [16] => expires: Sat, 11 Oct 2025 11:06:46 GMT [17] => vary: Accept-Encoding [18] => Report-To: {"group":"cf-nel","max_age":604800,"endpoints":[{"url":"https://a.nel.cloudflare.com/report/v4?s=HkGJQYc1G9aqHhx2AwXnNYITcqgoQLuNYHmD7joV7H21awN%2B9VRjiMV9LQMUTMGqshcYEn6oiTxQHLppHE09rTbC9%2BO7tsUlFHY39vY%3D"}]} [19] => cf-cache-status: DYNAMIC [20] => Speculation-Rules: "/cdn-cgi/speculation" [21] => Server-Timing: cfCacheStatus;desc="DYNAMIC" [22] => Server-Timing: cfEdge;dur=2,cfOrigin;dur=117 [23] => Set-Cookie: UpalLiveSession=eyJpdiI6ImtIV1lRRTVSNmZPd3lVUTRcLzdqSjdRPT0iLCJ2YWx1ZSI6Ijg2dHJPSFZVTUhcL0FTcVl4WjhUVkdDR2c3d1k4K2VcLzF6aVJQdFBXdlQxZUJEdldsenEzdW5mekVPRDZYTE14cVVHeFF5Q3ZUM20xZzNZMUt2XC9JalNRPT0iLCJtYWMiOiIzZDEwZDllMGRmYTdjYzBjYjFhN2ZmNTc5MWRmNmJiNzBkYjA5NGQ0OGIwMzlmZDczZjYwYjhhMTIyN2JiYTJjIn0%3D; HttpOnly; Path=/; Max-Age=94608000; Expires=Mon, 09 Oct 2028 11:06:46 GMT [24] => CF-RAY: 98c5a677cde20d0a-KUL [25] => alt-svc: h3=":443"; ma=86400 ) 789

 

 

新冠肺炎疫情持续，目前检测病毒多以核酸检验方式进行，出结果需约4小时。台湾的中央研究院周日表示，成功合成能辨识新冠肺炎病毒的蛋白质单株抗体群，将用作检测快筛装置的关键试剂。若成功量产，最快15至20分钟有检测结果。

中研院基因体研究中心研究员杨安指，快筛的关键在于其抗体试剂需能准确辨识新冠肺炎病毒，针对7种人类冠状病毒核蛋白抗原，从第一批46株单株抗体中，发现有1株抗体只对新冠肺炎病毒有反应，不会与嚴重急性呼吸系統綜合症（SARS）、中东呼吸综合征（MERS）病毒等交叉反应，可快速辨识是否感染。

研究院上月初开始研究快速合成新冠肺炎病毒核蛋白抗原，中研院院长廖俊智表示，下阶段将联同台湾的经济部与数家厂商讨论试剂生产，希望在3到4个月内通过台湾的卫福部验证，并进行临床试验。